Fig. 1 · Structure
Documents & Downloads
Flurbiprofen sodium
Cat. No.
A73212
CAS
56767-76-1
Endogenous Metabolite
Flurbiprofen sodium is a nonsteroidal anti-inflammatory drug (NSAID) targeting inflammatory pathways through the inhibition of carbonic anhydrase. It exhibits significant anti-inflammatory and analgesic properties, making it useful in the treatment of periodontal disease by reducing bone resorption. Additionally, Flurbiprofen sodium can be formulated into biodegradable microspheres for effective compound delivery, particularly within periodontal pockets, with the release kinetics influenced by the concentration of the polymer and polyvinyl alcohol used in its preparation. This compound is valuable for research into periodontal therapies and inflammation-related studies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 56767-76-1 |
| Applications | Endogenous Metabolite |
| Formula | C15H12FNaO2 |
| Molecular Weight | 266.24 |
| Synonyms | dl-Flurbiprofen sodium |
| SMILES | O=C(C(C)C1=CC(F)=C(C2=CC=CC=C2)C=C1)O[Na] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.